US 11279768
Anti-cancer antibodies, combination therapies, and uses thereof
granted A61KA61K2039/505A61K39/39558
Quick answer
US patent 11279768 (Anti-cancer antibodies, combination therapies, and uses thereof) held by PRECISION BIOLOGICS, INC. expires Mon Mar 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- PRECISION BIOLOGICS, INC.
- Grant date
- Tue Mar 22 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K2039/505, A61K39/39558, A61K45/06